Summary
There is currently no scientific evidence to suggest that Ozempic, a medication primarily used to manage type 2 diabetes, directly impacts testosterone. In fact, Ozempic can improve testosterone levels and erectile function by reducing weight and metabolic symptoms of type 2 diabetes.
What is Ozempic?
Ozempic, also known as semaglutide, is a prescription medication developed by Novo Nordisk. It is a modified human glucagon-like peptide-1 (GLP-1) analogue for treating type 2 diabetes mellitus. Ozempic is a formulation of semaglutide administered subcutaneously, meaning it is given as an injection under the skin. Other formulations of semaglutide, such as Rybelsus, can be taken in tablet form.
How Does Ozempic Work?
Ozempic works by lowering blood glucose levels by stimulating insulin release through stimulating GLP-1 receptors in the liver and brain. It also has the effect of lowering body weight by increasing satiety [1].
Ozempic Side Effects
As Ozempic is injected into the blood, mimics the role of GLP-1 and stimulates insulin release, it can also lead to multiple side effects including hypoglycaemia, gastrointestinal side effects, brain fog. Critically, Ozempic is unlikely to cause heart palpitations, making it safe for patients with cardiovascular conditions [2].
A common concern in people taking Ozempic is the sexual side effects of reduced erectile function or reduced testosterone. Reduced testosterone can also have a negative impact on mood, bone density and cognition [3]. Therefore, determining whether Ozempic can lower testosterone is a critical consideration to make with your healthcare provider when considering taking Ozempic.
Does Ozempic Lower Testosterone?
In brief, there is insufficient evidence to determine whether or not Ozempic lowers testosterone levels in men. One study looked at the effects of semaglutide on testosterone and this was in a rat model of testicular dysfunction, making the results difficult to generalise to the general population [4].
Another very recent study looked at individuals with hypogonadism, a condition characterised by reductions in the release of sex hormones. This study found that treating hypogonadal men with semaglutide increased testosterone levels and minimised ageing symptoms. However, markers of seminal fluid, sperm count and motility were unaffected. This study is promising since both diabetes and obesity, conditions for which Ozempic/semaglutide are used, can lead to hypogonadism.
...